医学
荟萃分析
内科学
肿瘤科
分级(工程)
危险系数
化疗
分布式文件系统
置信区间
癌症
新辅助治疗
比例危险模型
出版偏见
乳腺癌
计算机科学
土木工程
工程类
计算机安全
作者
Ronald Wu,Shuying Lin,Junze Chen,Gang Wang,Lulu Han
标识
DOI:10.14309/ctg.0000000000000860
摘要
INTRODUCTION: Tumor regression grade (TRG) after neoadjuvant chemotherapy is recognized as a significant and favorable prognostic indicator in various cancer types. However, this relationship remains less defined and has not been systematically investigated in locally advanced gastric cancer (LAGC). To address this gap, we conducted a meta-analysis aimed at assessing the prognostic influence of tumor regression after preoperative therapy on disease-free survival (DFS) and overall survival (OS) among patients with LAGC. METHODS: A systematic search was conducted across the following databases: PubMed, Web of Science, Embase, Cochrane, WF, CNKI, SinoMed, and VIP. The primary outcomes included DFS and OS, estimated using hazard ratios (HRs) and corresponding 95% confidence intervals (CIs). Subsequently, either the fixed-effects model or the random-effects model was used to compute HR and 95% CI based on the results of heterogeneity analysis. RESULTS: A total of 11 studies, comprising 2,733 patients, were included in the final analysis. The results indicated that a lower TRG was associated with prolonged DFS (HR 0.53, 95% CI 0.32-0.88) and prolonged OS (HR 0.59, 95% CI 0.39-0.87) in patients with LAGC who received neoadjuvant chemotherapy. Sensitivity analysis demonstrated that no single study significantly influenced the results for both DFS and OS. Publication bias was identified in the meta-analysis for OS, whereas no publication bias was detected in the meta-analysis for DFS. DISCUSSION: A lower TRG score is associated with improved DFS and OS in patients with LAGC receiving neoadjuvant chemotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI